Reported Tuberculosis in the United States, 2018
Resistance to anti-TB drugs is a serious problem both in the United States and globally. The best way to prevent drug resistance is to use the recommended combination therapy for treating TB disease and to use directly observed therapy (DOT) for ensuring adherence to the medication regimen.
Drug-resistance patterns are displayed in separate tables with drug-resistance trend data by previous TB status and origin of birth.
- Drug Resistance: Reporting Areas, 2018
- Characteristics of TB Estimated to be Attributed to Recent Transmission: 2017–2018
- TB by Resistance to Isoniazid (INH), Origin of Birth, and Previous History of TB: 1993–2018
- TB by Multidrug Resistance (MDR), Origin of Birth, and Previous History of TB: 1993–2018